RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 5,000.00
-130.00 (-2.53%)
At close: Nov 13, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 43.33 billion as of November 13, 2026. It is the 32,913th most valuable company in the world and the 1,855th biggest in South Korea. Its market cap has decreased by 36.39% in one year.
Market Cap
43.33B
Enterprise Value
42.81B
Revenue
141.42B
Global Rank
Country Rank
#1,855 South Korea
PE Ratio
6.43
ChartMarket Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 43.33B, a decrease of -69.74%. That is a compound annual growth rate of -25.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 43.33B | -32.43% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Optipharm.CO.,LTD | 64.69B |
| Sinsin Pharmaceutical | 59.01B |
| GL Pharm Tech | 51.65B |
| BL Pharmtech | 49.43B |
| Hwail Pharmaceutical | 45.60B |
| GeneBioTech Co. ,Ltd | 43.48B |
| Jin Yang Pharmaceutical | 43.44B |
| Eagle Veterinary Technology Co.,Ltd | 36.60B |